元隆雅圖(002878.SZ):作為成都大運會特許生產商及零售商、杭州亞運會特許零售商開發一系列特許產品
格隆匯5月6日丨元隆雅圖(002878.SZ)在5月5日15:00-17:00業績説明會上表示,公司正在將賽會特許和體育IP打造成常態化的持續性業務。成都大運會和杭州亞運會將於2023年下半年開幕,公司作為成都大運會特許生產商及零售商、杭州亞運會特許零售商開發了一系列特許產品,其中大運會蓉寶變臉盲盒深受消費者喜愛,一經推出便收穫了一定熱度。公司將借鑑冬奧會特許產品成功經驗,繼續大力投入大運會、亞運會特許產品開發,加強產品宣傳和渠道運營,力爭特許業務再創佳績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.